Investigation of a healthcare-associated candida infections in a Turkish intensive care unit: risk factors, therapy and clinical outcome

Basit Öğe Kaydı
dc.contributor.authorAvcioğlu, Fatma
dc.contributor.authorSirmatel, Fatma
dc.contributor.authorBehcet, Mustafa
dc.contributor.authorOzarslan, Oğulcan
dc.contributor.authorGözdaş, Hasan Tahsin
dc.date.accessioned2024-09-25T20:18:25Z
dc.date.available2024-09-25T20:18:25Z
dc.date.issued2021
dc.departmentAbant İzzet Baysal Üniversitesien_US
dc.description.abstractAim: Candida infections develop especially in intensive care unit (ICU) patients and increase the mortality rates. So, early and accurate diagnosis of Candida infections and determination of risk factors are very important. We aimed to retrospectively investigate Candida infections in terms of species and risk factors for candidemia caused by fungi. Methods: Candida infections in critically ill patients hospitalized in the Intensive Care Unit of Bolu Abant Izzet Baysal University Training and Research Hospital between January 2014 and December 2018 were retrospectively analyzed. The isolated Candida species were evaluated according to the sample types. The cases were investigated in terms of mortality due to candidiasis, previously used antibiotics and isolated Candida species. Results: 34 Candida species isolated from fungal cultures in ICUs were included in the study. Candida albicans (73.5%) was the most prevalent species isolated (NAC 26.5%). Patients with Candida isolated in their urine samples (76%) had a higher mortality rate than patients with Candida from other regions. Conclusion: The results of our study suggest that the highest rate of candidiasis (88%) is in patients who received beta-lactam antibiotic treatment. In addition, we think that when Candida species are detected in the urine samples of critically ill patients in the ICU, care should be taken in terms of candidiasis.en_US
dc.identifier.doi10.30714/j-ebr.2021165773
dc.identifier.endpage15en_US
dc.identifier.issn2618-6454
dc.identifier.issue1en_US
dc.identifier.startpage9en_US
dc.identifier.trdizinid417897en_US
dc.identifier.urihttps://doi.org/10.30714/j-ebr.2021165773
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/417897
dc.identifier.urihttps://hdl.handle.net/20.500.12491/15661
dc.identifier.volume4en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofExperimental Biomedical Researchen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzYK_20240925en_US
dc.titleInvestigation of a healthcare-associated candida infections in a Turkish intensive care unit: risk factors, therapy and clinical outcomeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu